Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biomacromolecules|March 2, 2012
Synthesis and assembly of functional high molecular weight adiponectin multimers in an engineered strain of Escherichia coliSheng Ding, Daniel M Pinkas, Annelise E Barron
Plos Biology|December 21, 2007
Transglutaminase 2 undergoes a large conformational change upon activationDaniel M Pinkas, Pavel Strop, Axel T Brunger, et al.
ACS Chemical Biology|January 8, 2011
Tunable, post-translational hydroxylation of collagen Domains in Escherichia coliDaniel M Pinkas, Sheng Ding, Ronald T Raines, et al.
The Journal of Biological Chemistry|June 16, 2010
Redox regulation of transglutaminase 2 activityJorunn Stamnaes, Daniel M Pinkas, Burkhard Fleckenstein, et al.
Biomaterials|July 9, 2010
Modular enzymatically crosslinked protein polymer hydrogels for in situ gelationNicolynn E Davis, Sheng Ding, Ryan E Forster, et al.
Structure (London, England : 1993)|August 27, 2024
A BTB extension and ion-binding domain contribute to the pentameric structure and TFAP2A binding of KCTD1Daniel M Pinkas, Joshua C Bufton, Alice E Hunt, et al.
The Biochemical Journal|October 1, 2017
Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligasesDaniel M Pinkas, Caroline E Sanvitale, Joshua C Bufton, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2018
Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitorsChalada Suebsuwong, Daniel M Pinkas, Soumya S Ray, et al.
Nature|October 18, 2013
Precision is essential for efficient catalysis in an evolved Kemp eliminaseRebecca Blomberg, Hajo Kries, Daniel M Pinkas, et al.
European Journal of Medicinal Chemistry|June 8, 2020
Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffoldChalada Suebsuwong, Bing Dai, Daniel M Pinkas, et al.
Pageof 2